<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Koole JL</submitter><funding>NICHD NIH HHS</funding><funding>European Research Area Network</funding><funding>Wereld Kanker Onderzoek Fonds</funding><funding>Health Foundation</funding><funding>National Cancer Institute</funding><funding>NHGRI NIH HHS</funding><funding>NCI NIH HHS</funding><pagination>1468-1481</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8168355</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>113(6)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>B vitamins have been associated with the risk and progression of colorectal cancer (CRC), given their central roles in nucleotide synthesis and methylation, yet their association with quality of life in established CRC is unclear.&lt;h4>Objectives&lt;/h4>To investigate whether quality of life 6 months postdiagnosis is associated with: 1) circulating concentrations of B vitamins and related biomarkers 6 months postdiagnosis; 2) changes in these concentrations between diagnosis and 6 months postdiagnosis; 3) B-vitamin supplement use 6 months postdiagnosis; and 4) changes in B-vitamin supplement use between diagnosis and 6 months postdiagnosis.&lt;h4>Methods&lt;/h4>We included 1676 newly diagnosed stage I-III CRC patients from 3 prospective European cohorts. Circulating concentrations </pubmed_abstract><journal>The American journal of clinical nutrition</journal><pubmed_title>Circulating B-vitamin biomarkers and B-vitamin supplement use in relation to quality of life in patients with colorectal cancer: results from the FOCUS consortium.</pubmed_title><pmcid>PMC8168355</pmcid><funding_grant_id>R01 CA189184</funding_grant_id><funding_grant_id>2014/1179</funding_grant_id><funding_grant_id>K12 HD043483</funding_grant_id><funding_grant_id>00005739</funding_grant_id><funding_grant_id>R01 CA207371</funding_grant_id><funding_grant_id>CA189184</funding_grant_id><funding_grant_id>2014-6877</funding_grant_id><funding_grant_id>2013-6397</funding_grant_id><funding_grant_id>U01 CA206110</funding_grant_id><funding_grant_id>T32 HG008962</funding_grant_id><pubmed_authors>Gigic B</pubmed_authors><pubmed_authors>Ulrich AB</pubmed_authors><pubmed_authors>Ose J</pubmed_authors><pubmed_authors>Lin T</pubmed_authors><pubmed_authors>Wesselink E</pubmed_authors><pubmed_authors>Vickers K</pubmed_authors><pubmed_authors>Ulvik A</pubmed_authors><pubmed_authors>Gumpenberger T</pubmed_authors><pubmed_authors>Ueland PM</pubmed_authors><pubmed_authors>Kok DE</pubmed_authors><pubmed_authors>van Halteren HK</pubmed_authors><pubmed_authors>Janssen-Heijnen MLG</pubmed_authors><pubmed_authors>Weijenberg MP</pubmed_authors><pubmed_authors>Li CI</pubmed_authors><pubmed_authors>Schrotz-King P</pubmed_authors><pubmed_authors>Habermann N</pubmed_authors><pubmed_authors>Ulrich CM</pubmed_authors><pubmed_authors>Breukink SO</pubmed_authors><pubmed_authors>Midttun O</pubmed_authors><pubmed_authors>Kruyt FM</pubmed_authors><pubmed_authors>Keulen ETP</pubmed_authors><pubmed_authors>Brezina S</pubmed_authors><pubmed_authors>Holowatyj AN</pubmed_authors><pubmed_authors>Chang-Claude J</pubmed_authors><pubmed_authors>Koole JL</pubmed_authors><pubmed_authors>Schneider MA</pubmed_authors><pubmed_authors>Baierl A</pubmed_authors><pubmed_authors>Bohm J</pubmed_authors><pubmed_authors>van Duijvendijk P</pubmed_authors><pubmed_authors>van Duijnhoven FJB</pubmed_authors><pubmed_authors>Peoples AR</pubmed_authors><pubmed_authors>Bours MJL</pubmed_authors><pubmed_authors>Kampman E</pubmed_authors><pubmed_authors>Geijsen AJMR</pubmed_authors><pubmed_authors>Brenner H</pubmed_authors><pubmed_authors>Kiblawi R</pubmed_authors><pubmed_authors>Gsur A</pubmed_authors><pubmed_authors>de Wilt JHW</pubmed_authors><pubmed_authors>van Roekel EH</pubmed_authors><pubmed_authors>Hoffmeister M</pubmed_authors></additional><is_claimable>false</is_claimable><name>Circulating B-vitamin biomarkers and B-vitamin supplement use in relation to quality of life in patients with colorectal cancer: results from the FOCUS consortium.</name><description>&lt;h4>Background&lt;/h4>B vitamins have been associated with the risk and progression of colorectal cancer (CRC), given their central roles in nucleotide synthesis and methylation, yet their association with quality of life in established CRC is unclear.&lt;h4>Objectives&lt;/h4>To investigate whether quality of life 6 months postdiagnosis is associated with: 1) circulating concentrations of B vitamins and related biomarkers 6 months postdiagnosis; 2) changes in these concentrations between diagnosis and 6 months postdiagnosis; 3) B-vitamin supplement use 6 months postdiagnosis; and 4) changes in B-vitamin supplement use between diagnosis and 6 months postdiagnosis.&lt;h4>Methods&lt;/h4>We included 1676 newly diagnosed stage I-III CRC patients from 3 prospective European cohorts. Circulating concentrations </description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Jun</publication><modification>2026-04-08T17:54:41.369Z</modification><creation>2025-02-18T23:32:30.553Z</creation></dates><accession>S-EPMC8168355</accession><cross_references><pubmed>33668069</pubmed><doi>10.1093/ajcn/nqaa422</doi></cross_references></HashMap>